These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23806155)

  • 1. Pemphigus: associations and management guidelines: facts and controversies.
    Ruocco E; Wolf R; Ruocco V; Brunetti G; Romano F; Lo Schiavo A
    Clin Dermatol; 2013; 31(4):382-390. PubMed ID: 23806155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pemphigus: a review].
    Joly P; Sin C
    Ann Dermatol Venereol; 2011 Mar; 138(3):182-200. PubMed ID: 21397148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?
    Tavakolpour S
    Int Immunopharmacol; 2017 Dec; 53():133-142. PubMed ID: 29107213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemphigus vulgaris: update on etiopathogenesis, oral manifestations, and management.
    Scully C; Challacombe SJ
    Crit Rev Oral Biol Med; 2002; 13(5):397-408. PubMed ID: 12393759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
    España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
    Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).
    Frew JW; Murrell DF
    Dermatol Clin; 2011 Oct; 29(4):607-12. PubMed ID: 21925005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pemphigus vulgaris: current and emerging options.
    Yeh SW; Sami N; Ahmed RA
    Am J Clin Dermatol; 2005; 6(5):327-42. PubMed ID: 16252932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus - Brazilian Society of Dermatology.
    Porro AM; Hans Filho G; Santi CG
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):20-32. PubMed ID: 31166407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pemphigus: current and future treatment strategies].
    Kussini J; Kaisers T; Sequeira Santos AM; Eming R; Didona D
    Dermatologie (Heidelb); 2022 Dec; 74(12):915-926. PubMed ID: 37902884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies.
    Zhao W; Wang J; Zhu H; Pan M
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):351-362. PubMed ID: 34350539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Infection in Pemphigus Vulgaris Two Weeks after Rituximab Therapy with Total Recovery: A Case Report.
    Róbert L; Kovács A; Sárdy M; Fábián M
    Acta Dermatovenerol Croat; 2023 Dec; 31(3):156-157. PubMed ID: 38439728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.
    Kasperkiewicz M; Shimanovich I; Meier M; Schumacher N; Westermann L; Kramer J; Zillikens D; Schmidt E
    Br J Dermatol; 2012 Jan; 166(1):154-60. PubMed ID: 21910700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies.
    Schiavo AL; Puca RV; Ruocco V; Ruocco E
    Clin Dermatol; 2010; 28(3):337-43. PubMed ID: 20541689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
    Saha M; Powell AM; Bhogal B; Black MM; Groves RW
    Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular non-Hodgkin's lymphoma with refractory paraneoplastic pemphigus: case report with review of novel treatment modalities.
    Rossum MM; Verhaegen NT; Jonkman MF; Mackenzie MA; Koster A; Van Der Valk PG; Span LF
    Leuk Lymphoma; 2004 Nov; 45(11):2327-32. PubMed ID: 15512825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of pemphigus.
    Tsuruta D; Ishii N; Hashimoto T
    Immunotherapy; 2012 Jul; 4(7):735-45. PubMed ID: 22853759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemphigus vulgaris: approach to treatment.
    Sinha AA; Hoffman MB; Janicke EC
    Eur J Dermatol; 2015 Apr; 25(2):103-13. PubMed ID: 25547117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of pemphigus].
    van Beek N; Zillikens D; Schmidt E
    Hautarzt; 2019 Apr; 70(4):243-253. PubMed ID: 30887081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris.
    Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T
    Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two decades of using the combination of tetracycline derivatives and niacinamide as steroid-sparing agents in the management of pemphigus: defining a niche for these low toxicity agents.
    McCarty M; Fivenson D
    J Am Acad Dermatol; 2014 Sep; 71(3):475-9. PubMed ID: 24906610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.